CN115003164A - 通过乳房内施用用于反刍动物的兽医用抗催乳素组合物 - Google Patents

通过乳房内施用用于反刍动物的兽医用抗催乳素组合物 Download PDF

Info

Publication number
CN115003164A
CN115003164A CN202180010827.9A CN202180010827A CN115003164A CN 115003164 A CN115003164 A CN 115003164A CN 202180010827 A CN202180010827 A CN 202180010827A CN 115003164 A CN115003164 A CN 115003164A
Authority
CN
China
Prior art keywords
composition
cabergoline
milk
ruminant
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180010827.9A
Other languages
English (en)
Chinese (zh)
Inventor
T·贝尔坦姆
A·德弗朗德尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceva Sante Animale SA
Original Assignee
Ceva Sante Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale SA filed Critical Ceva Sante Animale SA
Publication of CN115003164A publication Critical patent/CN115003164A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
CN202180010827.9A 2020-01-27 2021-01-26 通过乳房内施用用于反刍动物的兽医用抗催乳素组合物 Pending CN115003164A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20305066.1 2020-01-27
EP20305066 2020-01-27
PCT/EP2021/051766 WO2021151897A1 (en) 2020-01-27 2021-01-26 Veterinary anti-prolactin composition for ruminants used by intramammary administration

Publications (1)

Publication Number Publication Date
CN115003164A true CN115003164A (zh) 2022-09-02

Family

ID=69528716

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180010827.9A Pending CN115003164A (zh) 2020-01-27 2021-01-26 通过乳房内施用用于反刍动物的兽医用抗催乳素组合物

Country Status (16)

Country Link
US (1) US20230063100A1 (https=)
EP (1) EP4096428B1 (https=)
JP (1) JP7624999B2 (https=)
KR (1) KR20220132561A (https=)
CN (1) CN115003164A (https=)
AR (1) AR122365A1 (https=)
AU (1) AU2021213891A1 (https=)
BR (1) BR112022014708A2 (https=)
CA (1) CA3165962A1 (https=)
ES (1) ES2969031T3 (https=)
HU (1) HUE064769T2 (https=)
IL (1) IL294903A (https=)
MX (1) MX2022009177A (https=)
UY (1) UY39022A (https=)
WO (1) WO2021151897A1 (https=)
ZA (1) ZA202207808B (https=)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102215843A (zh) * 2008-10-07 2011-10-12 诗华动物保健股份有限公司 用于反刍动物的抗催乳素兽医学组合物
CN103476457A (zh) * 2011-02-15 2013-12-25 法国诗华大药厂 用于反刍动物的兽医用抗催乳素组合物
CN106389964A (zh) * 2016-11-21 2017-02-15 四川农业大学 一种奶牛回乳药物组合
US20190358154A1 (en) * 2018-05-23 2019-11-28 Boehringer Ingelheim Vetmedica Gmbh Use of an oral bolus in the drying-off of dairy cattle

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526892A (en) 1981-03-03 1985-07-02 Farmitalia Carlo Erba, S.P.A. Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102215843A (zh) * 2008-10-07 2011-10-12 诗华动物保健股份有限公司 用于反刍动物的抗催乳素兽医学组合物
CN103476457A (zh) * 2011-02-15 2013-12-25 法国诗华大药厂 用于反刍动物的兽医用抗催乳素组合物
CN106389964A (zh) * 2016-11-21 2017-02-15 四川农业大学 一种奶牛回乳药物组合
US20190358154A1 (en) * 2018-05-23 2019-11-28 Boehringer Ingelheim Vetmedica Gmbh Use of an oral bolus in the drying-off of dairy cattle

Also Published As

Publication number Publication date
EP4096428B1 (en) 2023-10-11
MX2022009177A (es) 2022-08-17
BR112022014708A2 (pt) 2022-10-11
CA3165962A1 (en) 2021-08-05
AU2021213891A1 (en) 2022-08-18
HUE064769T2 (hu) 2024-04-28
WO2021151897A1 (en) 2021-08-05
ES2969031T3 (es) 2024-05-16
AR122365A1 (es) 2022-09-07
IL294903A (en) 2022-09-01
JP7624999B2 (ja) 2025-01-31
JP2023511147A (ja) 2023-03-16
KR20220132561A (ko) 2022-09-30
EP4096428C0 (en) 2023-10-11
UY39022A (es) 2021-07-30
EP4096428A1 (en) 2022-12-07
US20230063100A1 (en) 2023-03-02
ZA202207808B (en) 2023-03-29

Similar Documents

Publication Publication Date Title
CN101588789B (zh) 用于治疗牛和其它动物炎症的药物组合物和方法
CN102215843B (zh) 抗催乳素兽医学组合物在制备药物中的用途
CN1291894A (zh) 用于治疗以高胰岛素血症、雄激素过多症、高脂血症和/或排卵停止为特征的代谢性疾病的含d－平性－肌醇的组合物
JP2005515213A (ja) ケトプロフェンを含む飲用可能な製剤と、熱、炎症、及び／又は、痛みを伴う症状に対する一群の動物の同時的治療でのその使用
CN115003164A (zh) 通过乳房内施用用于反刍动物的兽医用抗催乳素组合物
RU2846098C1 (ru) Ветеринарная антипролактиновая композиция для жвачных животных, используемая путем введения в молочную железу
CA2872396C (en) Pharmaceutical compositions for direct systemic introduction comprising a proton pump inhibitor
US11433021B2 (en) Palonosetron for the treatment or prevention of nausea and vomiting
EP4096429B1 (en) Veterinary composition for dairy ruminants for treatment of milk fever
CN115607545A (zh) 依达拉奉在自闭症谱系障碍治疗中的应用
US20220313774A1 (en) Intranasal administration of merotocin for improving lactation
TWI921225B (zh) Ｆｔｙ７２０用以製備改善卵巢的儲備功能之藥物的用途
US11819508B2 (en) Miltefosine for the treatment of viral infections including covid-19
JP2021172612A (ja) オキシトシンおよびプロトンポンプ阻害剤の組み合わせを含む薬剤
HK1161555B (en) Use of an antiprolactinic veterinary composition for the manufacture of a medicament

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination